Effects of Ibandronate on In Vitro Growth and Viability of 5TGM1 Cells
| Treatment Group . | Total Cell Number (×103) . | Percent Viability . |
|---|---|---|
| Control | 233.5 ± 8.9 | 93.9 ± 1.8 |
| IBN (10 μmol/L) | 199.8 ± 11.63-150 | 87.3 ± 3.0 |
| IBN (50 μmol/L) | 166.5 ± 13.03-150 | 69.0 ± 1.83-150 |
| IBN (100 μmol/L) | 78.0 ± 8.63-150 | 11.6 ± 5.03-150 |
| Treatment Group . | Total Cell Number (×103) . | Percent Viability . |
|---|---|---|
| Control | 233.5 ± 8.9 | 93.9 ± 1.8 |
| IBN (10 μmol/L) | 199.8 ± 11.63-150 | 87.3 ± 3.0 |
| IBN (50 μmol/L) | 166.5 ± 13.03-150 | 69.0 ± 1.83-150 |
| IBN (100 μmol/L) | 78.0 ± 8.63-150 | 11.6 ± 5.03-150 |
The effect of ibandronate (IBN) treatment for 72 hours on cell number and percent viability in cultures of 5TGM1 myeloma cells. Data are mean ± SEM (n = 4).
Significantly different from control.